232 related articles for article (PubMed ID: 30267229)
1. Prophylactic Cefazolin Dosing and Surgical Site Infections: Does the Dose Matter in Obese Patients?
Hussain Z; Curtain C; Mirkazemi C; Gadd K; Peterson GM; Zaidi STR
Obes Surg; 2019 Jan; 29(1):159-165. PubMed ID: 30267229
[TBL] [Abstract][Full Text] [Related]
2. Cefazolin dosing for surgical prophylaxis in morbidly obese patients.
Ho VP; Nicolau DP; Dakin GF; Pomp A; Rich BS; Towe CW; Barie PS
Surg Infect (Larchmt); 2012 Feb; 13(1):33-7. PubMed ID: 22316145
[TBL] [Abstract][Full Text] [Related]
3. [Dosage of presurgical cefazolin in obese and non-obese patients. Does weight matter?].
Rodríguez de Castro B; Martínez-Múgica Barbosa C; Pampín Sánchez R; Fernández González B; Barbazán Vázquez FJ; Aparicio Carreño C
Rev Esp Quimioter; 2020 Jun; 33(3):207-211. PubMed ID: 32295329
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of pre-operative cefazolin in obese patients.
Unger NR; Stein BJ
Surg Infect (Larchmt); 2014 Aug; 15(4):412-6. PubMed ID: 24824510
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Cefazolin Dosing in Women With Body Mass Index >35 kg·m-2 Undergoing Cesarean Delivery: A Pharmacokinetic Study of Plasma and Interstitial Fluid.
Eley VA; Christensen R; Ryan R; Jackson D; Parker SL; Smith M; van Zundert AA; Wallis SC; Lipman J; Roberts JA
Anesth Analg; 2020 Jul; 131(1):199-207. PubMed ID: 32250982
[TBL] [Abstract][Full Text] [Related]
6. Lack of Pharmacokinetic Basis of Weight-Based Dosing and Intra-Operative Re-Dosing with Cefazolin Surgical Prophylaxis in Obese Patients: Implications for Antibiotic Stewardship.
Blum S; Cunha CB; Cunha BA
Surg Infect (Larchmt); 2019 Sep; 20(6):439-443. PubMed ID: 31112072
[TBL] [Abstract][Full Text] [Related]
7. Association between Pre-Operative Cefazolin Dose and Surgical Site Infection in Obese Patients.
Peppard WJ; Eberle DG; Kugler NW; Mabrey DM; Weigelt JA
Surg Infect (Larchmt); 2017; 18(4):485-490. PubMed ID: 27906601
[TBL] [Abstract][Full Text] [Related]
8. Surgical site infection rate is higher following hip and knee arthroplasty when cefazolin is underdosed.
Morris AJ; Roberts SA; Grae N; Frampton CM
Am J Health Syst Pharm; 2020 Mar; 77(6):434-440. PubMed ID: 31950139
[TBL] [Abstract][Full Text] [Related]
9. Higher versus Lower Dose of Cefotetan or Cefoxitin for Surgical Prophylaxis in Patients Weighing One Hundred Twenty Kilograms or More.
Banoub M; Curless MS; Smith JM; Jarrell AS; Cosgrove SE; Rock C; Avdic E
Surg Infect (Larchmt); 2018 Jul; 19(5):504-509. PubMed ID: 29717917
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 2g vs 1 g of Prophylactic Cefazolin in Surgical Site Infections in Trauma Surgery Below the Knee.
Sanders FRK; Kistemaker RMG; van 't Hul M; Schepers T
Foot Ankle Int; 2020 May; 41(5):582-589. PubMed ID: 32026706
[TBL] [Abstract][Full Text] [Related]
11. Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women.
Swank ML; Wing DA; Nicolau DP; McNulty JA
Am J Obstet Gynecol; 2015 Sep; 213(3):415.e1-8. PubMed ID: 26003059
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Vancomycin and Cefazolin as Standard Preoperative Antibiotic Prophylaxis on Surgical Site Infections Following Instrumented Spinal Fusion.
Lopez WY; Rider SM; Nwosu K; Kazarian ER; Blucher JA; Schoenfeld EM; Simpson AK; Kang JD; Schoenfeld AJ
Spine (Phila Pa 1976); 2019 Mar; 44(6):E366-E371. PubMed ID: 30830037
[TBL] [Abstract][Full Text] [Related]
13. Does current cefazolin dosing achieve adequate tissue and blood concentrations in obese women undergoing cesarean section?
Kram JJF; Greer DM; Cabrera O; Burlage R; Forgie MM; Siddiqui DS
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():334-341. PubMed ID: 28122314
[TBL] [Abstract][Full Text] [Related]
14. Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing.
Chen X; Brathwaite CE; Barkan A; Hall K; Chu G; Cherasard P; Wang S; Nicolau DP; Islam S; Cunha BA
Obes Surg; 2017 Mar; 27(3):626-629. PubMed ID: 27520693
[TBL] [Abstract][Full Text] [Related]
15. Influence of body mass index and antibiotic dose on the risk of surgical site infections in pediatric clean orthopedic surgery.
Cies JJ; Chan S; Hossain J; Brenn BR; Di Pentima MC
Surg Infect (Larchmt); 2012 Dec; 13(6):371-6. PubMed ID: 23216453
[TBL] [Abstract][Full Text] [Related]
16. Impact of Intraoperative Continuous-Infusion Versus Intermittent Dosing of Cefazolin Therapy on the Incidence of Surgical Site Infections After Coronary Artery Bypass Grafting.
Shoulders BR; Crow JR; Davis SL; Whitman GJ; Gavin M; Lester L; Barodka V; Dzintars K
Pharmacotherapy; 2016 Feb; 36(2):166-73. PubMed ID: 26799442
[TBL] [Abstract][Full Text] [Related]
17. Wound infection following implant removal of foot, ankle, lower leg or patella; a protocol for a multicenter randomized controlled trial investigating the (cost-)effectiveness of 2 g of prophylactic cefazolin compared to placebo (WIFI-2 trial).
Sanders FRK; Penning D; Backes M; Dingemans SA; van Dieren S; Eskes AM; Goslings JC; Kloen P; Mathôt RAA; Schep NWL; Spijkerman IJB; Schepers T
BMC Surg; 2021 Feb; 21(1):69. PubMed ID: 33522909
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Duration of Prophylactic Post-Operative Antibiotic Agents after Open Reduction Internal Fixation for Closed Fractures.
Crist BD; Oladeji LO; Della Rocca GJ; Volgas DA; Stannard JP; Greenberg DD
Surg Infect (Larchmt); 2018 Jul; 19(5):535-540. PubMed ID: 29781787
[TBL] [Abstract][Full Text] [Related]
19. Cefazolin tissue concentrations with a prophylactic dose administered before sleeve gastrectomy in obese patients: a single centre study in 116 patients.
Cinotti R; Dumont R; Ronchi L; Roquilly A; Atthar V; Grégoire M; Planche L; Letessier E; Dailly E; Asehnoune K
Br J Anaesth; 2018 Jun; 120(6):1202-1208. PubMed ID: 29793587
[TBL] [Abstract][Full Text] [Related]
20. Extended antibiotic prophylaxis for prevention of surgical-site infections in morbidly obese women who undergo combined hysterectomy and medically indicated panniculectomy: a cohort study.
El-Nashar SA; Diehl CL; Swanson CL; Thompson RL; Cliby WA; Famuyide AO; Stanhope CR
Am J Obstet Gynecol; 2010 Mar; 202(3):306.e1-9. PubMed ID: 20207249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
